Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipocyte | 10 studies | 65% ± 17% | |
| hepatocyte | 6 studies | 66% ± 26% | |
| microglial cell | 6 studies | 25% ± 6% | |
| endothelial cell | 4 studies | 25% ± 1% | |
| glutamatergic neuron | 4 studies | 31% ± 16% | |
| type B pancreatic cell | 3 studies | 46% ± 19% | |
| enteroendocrine cell | 3 studies | 34% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 53438.75 | 226 / 226 | 98% | 159.46 | 399 / 406 |
| kidney | 98% | 6484.52 | 87 / 89 | 80% | 21.94 | 718 / 901 |
| pancreas | 97% | 2348.99 | 318 / 328 | 77% | 18.64 | 137 / 178 |
| brain | 73% | 2605.86 | 1926 / 2642 | 69% | 6.59 | 488 / 705 |
| adrenal gland | 100% | 14379.24 | 258 / 258 | 41% | 13.70 | 95 / 230 |
| intestine | 54% | 2125.16 | 525 / 966 | 87% | 27.80 | 458 / 527 |
| thymus | 62% | 1133.11 | 402 / 653 | 66% | 8.76 | 401 / 605 |
| ovary | 29% | 503.06 | 52 / 180 | 71% | 14.67 | 305 / 430 |
| breast | 85% | 8654.02 | 391 / 459 | 14% | 1.22 | 152 / 1118 |
| adipose | 99% | 11737.10 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 95% | 5817.25 | 766 / 803 | 0% | 0 | 0 / 0 |
| stomach | 13% | 238.72 | 46 / 359 | 73% | 23.12 | 209 / 286 |
| esophagus | 38% | 746.15 | 553 / 1445 | 44% | 9.72 | 80 / 183 |
| lung | 21% | 285.71 | 124 / 578 | 24% | 3.44 | 278 / 1155 |
| bladder | 10% | 120.86 | 2 / 21 | 32% | 7.50 | 163 / 504 |
| prostate | 22% | 345.90 | 55 / 245 | 4% | 0.31 | 22 / 502 |
| uterus | 5% | 139.12 | 8 / 170 | 17% | 3.01 | 78 / 459 |
| skin | 17% | 294.86 | 312 / 1809 | 3% | 0.28 | 16 / 472 |
| blood vessel | 13% | 455.36 | 168 / 1335 | 0% | 0 | 0 / 0 |
| heart | 8% | 137.98 | 69 / 861 | 0% | 0 | 0 / 0 |
| spleen | 0% | 48.18 | 1 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 2.48 | 2 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0097009 | Biological process | energy homeostasis |
| GO_0070328 | Biological process | triglyceride homeostasis |
| GO_0055089 | Biological process | fatty acid homeostasis |
| GO_0000432 | Biological process | positive regulation of transcription from RNA polymerase II promoter by glucose |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0045723 | Biological process | positive regulation of fatty acid biosynthetic process |
| GO_0046889 | Biological process | positive regulation of lipid biosynthetic process |
| GO_0008610 | Biological process | lipid biosynthetic process |
| GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
| GO_0090324 | Biological process | negative regulation of oxidative phosphorylation |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0009653 | Biological process | anatomical structure morphogenesis |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0033137 | Biological process | negative regulation of peptidyl-serine phosphorylation |
| GO_0045821 | Biological process | positive regulation of glycolytic process |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0042593 | Biological process | glucose homeostasis |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0010255 | Biological process | glucose mediated signaling pathway |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000785 | Cellular component | chromatin |
| GO_0005667 | Cellular component | transcription regulator complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0140297 | Molecular function | DNA-binding transcription factor binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0035538 | Molecular function | carbohydrate response element binding |
| GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0001216 | Molecular function | DNA-binding transcription activator activity |
| GO_0046982 | Molecular function | protein heterodimerization activity |
| Gene name | MLXIPL |
| Protein name | Williams-Beuren syndrome chromosome region 14 protein 2 MLX interacting-like protein HCG18989, isoform CRA_h (MLX interacting protein like) Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein) MLX interacting protein like |
| Synonyms | BHLHD14 MIO WBSCR14 hCG_18989 |
| Description | FUNCTION: Binds DNA as a heterodimer with MLX/TCFL4 and activates transcription. Binds to the canonical E box sequence 5'-CACGTG-3'. Plays a role in transcriptional activation of glycolytic target genes. Involved in glucose-responsive gene regulation (By similarity). Regulates transcription in response to changes in cellular carbohydrate abundance such as occurs during fasting to feeding metabolic transition. Refeeding stimulates MLXIPL/ChREBP transcription factor, leading to increased BCKDK to PPM1K expression ratio, phosphorylation and activation of ACLY that ultimately results in the generation of malonyl-CoA and oxaloacetate immediate substrates of de novo lipogenesis and gluconeogenesis, respectively (By similarity). . |
| Accessions | S5M7A5 ENST00000429400.6 [Q9NP71-2] ENST00000345114.9 [Q9NP71-5] S5LSP3 ENST00000414749.6 [Q9NP71-3] Q9NP71 ENST00000453275.1 ENST00000354613.5 [Q9NP71-4] ENST00000313375.8 [Q9NP71-1] ENST00000434326.5 C5HU01 C9JDF5 ENST00000456640.2 S5LVX6 H7C1V3 A0A0C4DG26 |